Journal article
Anti‐vascular endothelial growth factor therapy and retinal non‐perfusion in diabetic retinopathy: A meta‐analysis of randomised trials
Abstract
PURPOSE: Retinal non-perfusion (RNP) is fundamental to disease onset and progression in diabetic retinopathy (DR). Whether anti-vascular endothelial growth factor (anti-VEGF) therapy can modify RNP progression is unclear. This investigation quantified the impact of anti-VEGF therapy on RNP progression compared with laser or sham at 12 months.
METHODS: A systematic review and meta-analysis of randomised controlled trials (RCTs) were performed; …
Authors
Nanji K; Sarohia GS; Xie J; Patil NS; Phillips M; Zeraatkar D; Thabane L; Guymer RH; Kaiser PK; Sivaprasad S
Journal
Acta Ophthalmologica, Vol. 102, No. 1, pp. e31–e41
Publisher
Wiley
Publication Date
2 2024
DOI
10.1111/aos.15673
ISSN
1755-375X